BetterLife Pharma (BETRF) Invested Capital (2011 - 2026)

BetterLife Pharma's Invested Capital history runs 16 years deep, the most recent figure standing at $1.2 million for Q2 2026.

• In Q2 2026, Invested Capital rose 100.48% year-over-year to $1.2 million; the TTM figure through Apr 2026 stood at $2.7 million (up 17.39% YoY), while the FY2026 annual figure was $297490.1, up 10.43% from the prior year.
• Invested Capital for Q2 2026 stood at $1.2 million, up from $297490.1 in the prior quarter.
• The five-year high for Invested Capital was $1.2 million in Q2 2026, with the low at $257693.4 in Q2 2022.
• The 5-year median for Invested Capital is $645213.8 (2024), against an average of $632532.4.
• The sharpest annual moves came in 2022 and 2025: Invested Capital jumped 504.34% in 2022, then sank 68.09% in 2025.
• BetterLife Pharma's Invested Capital stood at $554073.8 in 2022, then rose by 27.7% to $707545.0 in 2023, then increased by 15.85% to $819657.3 in 2024, then dropped by 16.24% to $686517.0 in 2025, then soared by 67.76% to $1.2 million in 2026.
• Business Quant data shows BETRF's Invested Capital at $1.2 million in Q2 2026, $297490.1 in Q1 2026, and $686517.0 in Q3 2025.